NEW YORKand DUBAI, United Arab Emirates, Dec. 15, 2021 /PRNewswire/ --Secondcell Bioand Alliance Care Technologies Internationaland announce new strategic partnership using Chromovert Technology to establish a novel, cutting-edge research focused on cell technology and rapid drug discovery to combat rare genetic diseases in the United Arab Emirates.
Chromovert has been extensively validated to streamline a key step of the drug discovery process by a boutique biotechnology company co-founded by its inventor, Dr. Kambiz Shekdar, PhD and the late Nobel-laureate Dr. Gunter Blobel, MD, PhD of The Rockefeller University. The present initiative aims to make revolutionary advancements by scaling-up and applying the demonstrated biotechnology to implement drug discovery at scale, with targets including CNS indications, COVID/Pulmonary Edema (ENaC), orphan and rare diseases and Thalassemia.
In the pharmaceutical drug discovery and development process, Chromovert is a cutting-edge technology that goes beyond CRISPR by enabling the creation of previously out-of-reach designer cells for improved drug discovery. The novel technology was published for the first time in March 2021 by Springer Nature: Cell engineering method using fluorogenic oligonucleotide signaling probes and flow cytometry.Founded by Dr. Shekdar,Secondcell Biobrings optimized materials and methods to operate Chromovert Technology to market.
According to Dr. Shekdar, "Our technology can have a global impact on genetics and cell research, particularly in the area of rare genetic diseases drug discovery. At this stage we want to partner with companies that are positioned to move quickly to advance current research toward finding cures. We are excited at the prospect of joining the healthcare revolution taking place in the UAE and having the opportunity to work with the best researchers from across the globe."
Alliance Care Technologies International CEO Michele Tarnow echoes those sentiments. "We have the privilege to work with the UAE's leading hospitals and research centers. By helping to bring Secondcell Bio and Dr. Shekdar's research to the UAE, we help the Emirates achieve their goal of becoming the leader in global health care by 2030. We are excited to work alongside Dr. Shekdar to bring this cutting-edge research to the UAE."
As part of the expansion into the UAE, a world class Scientific Advisory Board will be appointed to identify and prioritize additional therapeutic indications. Dr. Shekdar notes, "As whole genome sequencing of individuals and analysis by AI increases, additional drug targets will be identified, including for personalized medicine. By strategically locating in the UAE, we enhance data collection in that region and can prioritize drug discovery against new and relevant targets."
Tarnow notes additional advantages to working with Secondcell Bio and Chromovert. "In addition to the promising research advances that can be achieved, the advanced technology used to develop S4, our Syndromic Surveillance solution, has the potential to enhance Secondcell Bio data collection. We are excited to explore ways we can collaborate to improve health care across multiple sectors."
Previously, Chromovert was used to create exceedingly rare laboratory cells that accurately mimic the biology of human pain perception, resulting in the discovery and development of a novel clinical-stage pain blocker fast-tracked by the FDA and presented at The White House as part of Governor Chris Christie's panel on the opioid epidemic. The biotechnology was also the subject of a $100M+ natural flavors discovery engine implemented with The Coca-Cola Company, Kraft Foods and Nestle to create human tastebud-like cells for miniaturized turbo taste testing of natural extracts to discover exquisite natural flavors to cut sodium and sugar in the diet.
Demonstrating the breadth and range of technology, Drs. Shekdar and Blobel also established Research Foundation to Cure AIDS (RFTCA) based upon Chromovert. RFTCA is a U.S. 501(c)3 not-for-profit organization seeking to develop a global cure for AIDS by using Chromovert to increase the efficiency of promising, but stunted, investigational cell therapy strategies to cure HIV infection. Sickle Cell Disease, Thalassemia and certain other diseases also stand to benefit by the addition of Chromovert Technology.
The strategic partnership by ACTI and Secondcell aims to realize the full potential of the technology to discover and develop a pipeline of candidate drugs for diseases with unmet need. Currently, the industry average failure rate for drug discovery programs in pharmaceutical companies is reported to be approximately 98%. One key factor contributing to the high failure rate is the lack of cells that accurately mimic the biology of human disease in the laboratory dish. Chromovert Technology has been demonstrated to permit the rapid creation of laboratory cells that accurately mimic human disease, allowing for the improved discovery of candidate drug molecules with a greater overall likelihood of success.
ACTI and Secondcell Bio invite researchers, entrepreneurs and investors interested in learning more about current research, collaborations or investment opportunities to contact for more information.
About Secondcell Bio and Chromovert Technology
Secondcell Bio is a biotechnology company established to achieve previously inaccessible goals in cell and genetic engineering via dedicated research and commercialization partnerships.
Chromovert Technology enables creation of highly desired but previously out-of-reach cells for improved drug discovery. The technology was invented by Dr. Kambiz Shekdar in the Nobel-Prize winning laboratory of the late Gunter Blobel, MD, PhD, at The Rockefeller University. Materials and methods to operate Chromovert are available for research use only from Secondcell Bio at https://www.secondcellbio.com/.
Link to detailed scientific publication on Chromovert Technology:https://link.springer.com/article/10.1007/s10529-021-03101-5
About Alliance Care Technologies International
Alliance Care Technologies International (ACTI) is driven by a mission to provide global access to quality healthcare. At Alliance Care Technologies International, we believe global health is improved when physicians, patients, researchers and entrepreneurs work together to improve quality and efficiency across the continuum of healthcare.
Alliance Care Technologies International develops and deploys advanced technology and artificial intelligence solutions that solve today's most pressing healthcare challenges. We work with industry leaders to design individualized solutions that enhance the patient experience, streamline administrative processes, manage costs, and ultimately, improve healthcare outcomes.
https://www.alliancecaretech.com/
Link to detailed press on Secondcell Bio: https://www.prnewswire.com/news-releases/secondcell-bio-publishes-biotechnology-for-improved-drug-discovery-originating-from-the-rockefeller-university-301377258.html
Contact InformationSecondcell Bio[emailprotected]
SOURCE Secondcell Bio
See the original post:
DRUG DISCOVERY PARTNERSHIP ANNOUNCED IN UAE USA - PRNewswire
- Viewpoint: Anti-GMO arguments seem silly after 28 years of false narratives about health harms and and genetic ... - Genetic Literacy Project - March 29th, 2024 [March 29th, 2024]
- Viewpoint: Here's how genetically engineered fruits and vegetables will soon emerge as a grocery store 'selling point ... - Genetic Literacy Project - March 29th, 2024 [March 29th, 2024]
- CRISPR Investments: What We Heard at World Agri-Tech - Seed World - March 29th, 2024 [March 29th, 2024]
- When SpaceX's Starship is ready to settle Mars, will we be? (op-ed) - Space.com - September 17th, 2023 [September 17th, 2023]
- Genome-wide promoter responses to CRISPR perturbations of ... - Nature.com - September 17th, 2023 [September 17th, 2023]
- Expanding the toolbox for RNA editing | ASU News - ASU News Now - September 17th, 2023 [September 17th, 2023]
- Electrical Engineer Named MIT Technology Review Innovator Under ... - University of California San Diego - September 17th, 2023 [September 17th, 2023]
- Can we rely on our 'moral force-field' to stop cloning going too far? - The National - September 17th, 2023 [September 17th, 2023]
- Otsuka Collaborates with ShapeTX for Development of AAV Gene ... - Pharmaceutical Technology Magazine - September 17th, 2023 [September 17th, 2023]
- Cancer discovery earns U of A grad the Breakthrough Prize - University of Alberta - September 17th, 2023 [September 17th, 2023]
- The Brave New World of synthetic humans | Gne Taylor - IAI - September 17th, 2023 [September 17th, 2023]
- Targeting Tumors with Photosynthetic Bacteria - Optics & Photonics News - September 17th, 2023 [September 17th, 2023]
- Artificial Photosynthesis Breakthrough Researchers Produce ... - SciTechDaily - September 17th, 2023 [September 17th, 2023]
- BASF patent on watermelons upheld: European Patent Office rejects ... - Bio Eco Actual - September 17th, 2023 [September 17th, 2023]
- Space Industry Is Growing Faster Than Its Workforce, Analysts Say - Slashdot - September 17th, 2023 [September 17th, 2023]
- New 'Inverse Vaccine' Shows Potential to Treat MS and Other ... - Slashdot - September 17th, 2023 [September 17th, 2023]
- Gene therapy: Donor DNA may protect babies from certain disorders - Medical News Today - May 18th, 2023 [May 18th, 2023]
- Viewpoint: Grim consequences of Greenpeace's war on ... - Genetic Literacy Project - May 18th, 2023 [May 18th, 2023]
- Predicting Diabetic Kidney Disease with the Use of a Novel Algorithm - Genetic Engineering & Biotechnology News - May 18th, 2023 [May 18th, 2023]
- Quantum biology on horizon? How futuristic physics theory could ... - Study Finds - May 18th, 2023 [May 18th, 2023]
- Scientists can collect human DNA from water, air, and basically ... - Earth.com - May 18th, 2023 [May 18th, 2023]
- The First Crispr-Edited Salad Is Here - WIRED - May 18th, 2023 [May 18th, 2023]
- Gene editing technology used to produce disease-resistant calf - Earth.com - May 18th, 2023 [May 18th, 2023]
- Neanderthals passed down their tall noses to modern humans ... - Livescience.com - May 18th, 2023 [May 18th, 2023]
- Squid Camouflage Inspires Human Invisibility: Is it Possible? - DISCOVER Magazine - May 18th, 2023 [May 18th, 2023]
- Mice Model Technologies Market Poised for 7.4% CAGR Growth, Reaching USD 3.2 Bn by 2031 | Transparency Market Research - Yahoo Finance - May 18th, 2023 [May 18th, 2023]
- Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine - CNBC - May 18th, 2023 [May 18th, 2023]
- How Fauci, scientists with ties to Wuhan lab persuaded the ... - U.S. Right to Know - May 18th, 2023 [May 18th, 2023]
- The Daunting Task of Cutting Heavy Metals from Baby Food - Undark Magazine - May 18th, 2023 [May 18th, 2023]
- Ingestible Device Profiles and Peers into the Microbiome and ... - Genetic Engineering & Biotechnology News - May 18th, 2023 [May 18th, 2023]
- X-Men Officially Names the Best Powers Any Mutant Can Have - Screen Rant - May 18th, 2023 [May 18th, 2023]
- 10 Forgotten Marvel Comics Characters That Debuted In The '80s - Screen Rant - May 18th, 2023 [May 18th, 2023]
- 18 Human Genetic Engineering - Clemson University - April 19th, 2023 [April 19th, 2023]
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 31st, 2023 [March 31st, 2023]
- What is Genetic Engineering? Types, Process & Applications - March 31st, 2023 [March 31st, 2023]
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 31st, 2023 [March 31st, 2023]
- Welcome to the UNC Department of Genetics | Department of Genetics - February 5th, 2023 [February 5th, 2023]
- Global Genetically Modified Crops Market Is Projected To Grow At A 6% Rate Through The Forecast Period - EIN News - February 5th, 2023 [February 5th, 2023]
- Science and History of GMOs and Other Food Modification Processes - February 2nd, 2023 [February 2nd, 2023]
- Genetics | History, Biology, Timeline, & Facts | Britannica - January 31st, 2023 [January 31st, 2023]
- Human genetics | Description, Chromosomes, & Inheritance - January 31st, 2023 [January 31st, 2023]
- Genetic testing - Mayo Clinic - January 31st, 2023 [January 31st, 2023]
- Genetic Disorders: What Are They, Types, Symptoms & Causes - January 31st, 2023 [January 31st, 2023]
- Colossal Biosciences Project to Revive the Prehistoric Woolly Mammoth Raises Staggering $60 Million Series A Funding - Nature World News - January 22nd, 2023 [January 22nd, 2023]
- 2023 is going to witness a surge in technology courses top courses that will remain in vogue - Times of India - January 22nd, 2023 [January 22nd, 2023]
- M.R.S. Rao birthday: All you need to know about the Padma Shri winning Indian scientist - Free Press Journal - January 22nd, 2023 [January 22nd, 2023]
- Russian cosmism - Wikipedia - January 8th, 2023 [January 8th, 2023]
- Postgenderism - Wikipedia - January 8th, 2023 [January 8th, 2023]
- LessWrong - Wikipedia - January 8th, 2023 [January 8th, 2023]
- Eliezer Yudkowsky - Wikipedia - January 8th, 2023 [January 8th, 2023]
- Genetic Engineering Principles of Biology - December 26th, 2022 [December 26th, 2022]
- Engineering the Perfect Baby | MIT Technology Review - December 26th, 2022 [December 26th, 2022]
- Genetic Engineering Science Projects - Science Buddies - December 21st, 2022 [December 21st, 2022]
- DSI adoption at COP15 can financially help protect biodiversity in India: Experts - The Tribune India - December 21st, 2022 [December 21st, 2022]
- Tel Aviv University researchers demonstrate success of potential one-time vaccine to treat HIV/AIDS - ETHealthWorld - December 21st, 2022 [December 21st, 2022]
- Should You Buy 22nd Century Group Inc (XXII) Stock After it Has Risen 14.29% in a Week? - InvestorsObserver - October 28th, 2022 [October 28th, 2022]
- Home :: National Institute for Biotechnology and Genetic Engineering - October 11th, 2022 [October 11th, 2022]
- A recently discovered law of physics could help predict genetic mutations - October 11th, 2022 [October 11th, 2022]
- Farmers, consumers will embrace GMOs if they understand them - The Standard - October 11th, 2022 [October 11th, 2022]
- Synthetic Biology Market is Expected to Report a CAGR of ~21% from 2021 to 2029: Industry Size, Growth & Forecast at Douglas Insights - Yahoo... - October 11th, 2022 [October 11th, 2022]
- After 45 years of science-based art, Esther Klein Gallery winds down - WHYY - October 11th, 2022 [October 11th, 2022]
- Behind this Nobel prize is a very human story: theres a bit of Neanderthal in all of us - The Guardian - October 11th, 2022 [October 11th, 2022]
- The key to tastier beer might be mutant yeastwith notes of banana - Popular Science - October 11th, 2022 [October 11th, 2022]
- Why You'll Probably Never See Cotton Candy Grape Wine - Tasting Table - October 11th, 2022 [October 11th, 2022]
- Earth materials in technology The National - The National - October 11th, 2022 [October 11th, 2022]
- CULINARY THRILL SEEKING Proceed with caution. It's hotter than blazes season. - Port Arthur News - The Port Arthur News - October 11th, 2022 [October 11th, 2022]
- Give legal rights to animals, trees and rivers, say experts - The Guardian - October 11th, 2022 [October 11th, 2022]
- How yeast DNA may help protect astronauts from cosmic radiation in space - EastMojo - October 11th, 2022 [October 11th, 2022]
- Life finds a way, but should it? The ethics of genetic engineering - The Trinitonian - October 8th, 2022 [October 8th, 2022]
- To modify or not to modify? Genetic Modification and Gene Editing - A divergence by the UK - Lexology - October 8th, 2022 [October 8th, 2022]
- Gene Therapy Hits Its Stride in the Clinic - Genetic Engineering & Biotechnology News - October 8th, 2022 [October 8th, 2022]
- GWAS, MWAS and mGWAS provide insights into precision agriculture based on genotype-dependent microbial effects in foxtail millet - Nature.com - October 8th, 2022 [October 8th, 2022]
- Making Sense of the Latest Apple-iPhone News - The Motley Fool - October 8th, 2022 [October 8th, 2022]
- Gene therapy brings hope to people with sickle cell, HIV - Monitor - October 8th, 2022 [October 8th, 2022]
- GMO: Everything you need to know about lifting ban - FarmKenya Initiative - The Standard - October 8th, 2022 [October 8th, 2022]
- Century Therapeutics to Present at the SITC 37th Annual Meeting - Yahoo Finance - October 8th, 2022 [October 8th, 2022]
- Cultured meat could help solve the climate crisis. Heres what it will take to move it from the lab to the dinner table - Fortune - October 8th, 2022 [October 8th, 2022]
- Poseida Therapeutics to Present Trial in Progress Poster for Phase 1 P-MUC1C-ALLO1 Study at the Society for Immunotherapy of Cancer Annual Meeting -... - October 8th, 2022 [October 8th, 2022]
- Explained: How scientists engineered mosquitoes that will cut the transmission of malaria - Firstpost - October 8th, 2022 [October 8th, 2022]
- Here Are the Biggest Health Industry News Items of 2022 So Far - DocWire News - October 8th, 2022 [October 8th, 2022]